The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis

Mise à jour : Il y a 4 ans
Référence : NCT00405665

Femme et Homme

  • | Pays :
  • Canada
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The objective of this trial is to determine the safety and effect on pulmonary function of 14 days of inhaled L-arginine versus placebo administered over a period of 14 days in a cohort of CF patients.


Critère d'inclusion

  • Cystic fibrosis

Liens